Exagen (XGN) Share-based Compensation (2018 - 2026)
Exagen (XGN) reported Share-based Compensation of $655000.0 for Q1 2026, up 57.07% on a YoY basis from $417000.0 in Q1 2025, and down 7.09% quarter-over-quarter from $705000.0 in Q4 2025.
Exagen (XGN) Share-based Compensation (2018 - 2026) Analysis & Trends
Exagen has reported Share-based Compensation for 9 years, with the latest figure at $655000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 57.07% year-over-year to $655000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 47.26% YoY), and the FY2025 full-year result was $2.2 million, up 22.4% from the prior year.
- Share-based Compensation for Q1 2026 stood at $655000.0, down from $705000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $1.4 million in Q2 2022, with the low at $217000.0 in Q3 2024.
- Historically, Share-based Compensation has averaged $758647.1 across 5 years, with a median of $655000.0 in 2026.
- Annual changes were most pronounced in 2024 — Share-based Compensation sank 75.62% — and 2025, when it soared 173.27%.
- Exagen's Share-based Compensation stood at $582000.0 in 2022, then soared by 31.1% to $763000.0 in 2023, then slumped by 43.25% to $433000.0 in 2024, then jumped by 62.82% to $705000.0 in 2025, then declined by 7.09% to $655000.0 in 2026.
- The last three Share-based Compensation figures came in at $655000.0 (Q1 2026), $705000.0 (Q4 2025), and $593000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 20.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 83.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 58.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 16.34 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 95.11 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 65.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 60.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 5.47 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | 655,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 655,000.00 |
| Mar 31, 2026 | 655,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Dec 31, 2025 | 705,000.00 |
| Sep 30, 2025 | 593,000.00 |
| Sep 30, 2025 | 593,000.00 |
| Jun 30, 2025 | 443,000.00 |
| Jun 30, 2025 | 443,000.00 |
| Mar 31, 2025 | 417,000.00 |
| Mar 31, 2025 | 417,000.00 |
| Dec 31, 2024 | 433,000.00 |
| Dec 31, 2024 | 433,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 553,000.00 |
| Mar 31, 2024 | 553,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Dec 31, 2023 | 763,000.00 |